BrainAurora Medical Technology Ltd (HKSE:06681) Share Price

Company Profile

Business description
BrainAurora Medical Technology Ltd is a player in China’s cognitive impairment digital therapeutics (the DTx) market. It has developed a medical-grade DTx product for cognitive impairment, combining brain science with artificial intelligence (the AI) technologies, Its product pipeline include range of cognitive impairments induced by vascular diseases, neurodegenerative diseases, psychiatric disorders, and child development deficiencies, among others. The company is engaged in provision of the System integral software solutions in hospitals and out of hospitals and research project. Geographically, the company generates all of its revenue from the PRC.
Contact
No. 2 Pingjiang Road
Room 1301, 13th floor, Building 3, Shaoxing
Shuimuwan District Science Park
Yuecheng District, Zhejiang Province
Shaoxing
CHN
T: +86 4008053066
https://www.66nao.cn
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
165

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,990.80	20.60	0.23%
CAC 40	8,131.77	26.05	-0.32%
DAX 40	24,065.12	63.86	-0.26%
Dow JONES (US)	49,057.09	173.62	-0.35%
FTSE 100	10,320.18	58.90	-0.57%
HKSE	25,925.65	52.42	-0.20%
NASDAQ	24,765.12	71.48	-0.29%
Nikkei 225	60,537.36	821.18	1.38%
NZX 50 Index	12,874.94	9.99	-0.08%
S&P 500	7,154.13	10.95	-0.15%
S&P/ASX 200	8,766.40	17.20	0.20%
SSE Composite Index	4,086.34	6.44	0.16%